The National Institutes of Health launched the RECOVER Initiative to understand, prevent, and ultimately treat Long COVID.

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug used to treat bone marrow cancer and Kaposi sarcoma is ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic ...

THIS-NC seeks to address health inequities by involving trusted safety net providers in research, to overcome historical ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has been awarded a $2 million Direct ...

Many clinical trials of new cancer drugs may be inappropriately excluding some people with Duffy-null phenotype, a trait found predominantly in people of African or Middle Eastern descent, researchers ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of ...

Three senior figures at the US National Institutes of Health explain why the agency remains committed to supporting basic science and research.

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining the current process for emergency use authorization for ...

The average readability of informed consent forms of federally funded clinical trials exceeds the reading comprehension ...

University of Utah Health approached a half-billion dollars ($492.3 million) in research funding in fiscal year 2024.